XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 3601-3604

  Duan, Wei Hong ^a   Zhu, Zhen Yu ^a   Liu, Jun Gui ^a   Dong, Mao Sheng ^a   Chen, Jun Zhou ^a   Liu, Quan Dda ^a   Xie, Yu ^a   Sun, Ti Ye ^a   Gao, Ze Feng ^b   Zhou, Ning Xin ^a  

^a PLA Erpao General Hospital   (China)

^b Shanxi Province Tumor Hospital   (China)

Author keywords

Arg399Gln; Gene polymorphism; Hepatocellular carcinoma; Meta analysis; Risk

Indexed keywords

EID: 84873664379     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.3601     Document Type: Article

References (23)

1. Chen CC, Yang SY, Liu CJ, et al (2005). Association of cytokine and DNA repair gene polymorphisms with hepatitis Brelated hepatocellular carcinoma. Int J Epidemiol, 34, 1310-8.
2. Cui Z, Yin Z, Li X, et al (2012). Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. BMC Cancer, 12, 71.
3. Dufloth RM, Costa S, Schmitt F, et al (2005). DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res, 30, 771-82.
4. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer, 127, 2893-917.
5. Forner A, Llovet JM, Bruix J (2012). Hepatocellular carcinoma. Lancet, 379, 1245-55.
6. Geng J, Zhang YW, Huang GC, et al (2008). XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. World J Gastroenterol, 14, 6733-7.
7. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
8. Kirk GD, Turner PC, Gong Y, et al (2005). Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitisBvirus endemicity. Cancer Epidemiol Biomarkers Prev, 14, 373-9.
9. Lindahl T, Wood RD (1999). Wood. Quality control by DNA repair. Science, 286, 1897-905.
10. Liu Y, Chen H, Chen L, et al (2012). Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population. Hepatogastroenterology, 59, 977-80.
11. Long XD, Ma Y, Wei YP, et al (2005). X-ray repair cross-complementing group 1(XRCC1) Arg 399 GIn polymorphism and aflatoxin B1(AFB1)-related hepatocellular carcinoma(HCG) in Guangxi population. Chin J Cancer Res, 17, 17-21.
12. Long XD, Ma Y, Wei YP, et al (2006). The polymorphisms of GSTM1, GSTT1, HYL1_2, and XRCC1, and aflatoxin B1- related hepatocellular carcinoma in Guangxi population, China. Hepatol Res, 36, 48-55.
13. Ren Y, Wang DS, Li Z, et al (2008). Study on the relationship between Gene XRCC1 Codon 399 S ingle Nucleotide Polymorphisms and Primary Hepatic Carcinoma in Han Nationality. Chin J Clin Hepatol, 24, 361-4 (article in Chinese).
14. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8.
15. Tang YT, Li XP, Liu TQ, et al (2011). Genetic poIymorphisms of DNA repair genes in patients with hepatocellular carcinoma. J Shandong Med, 51,19-20 (article in Chinese).
16. Tahara T, Shibata T, Nakamura M, et al (2009). Effect of polymorphisms in the 3' untranslated region (3'- UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog, 48, 1030-7.
17. Thompson LH, West MG (2000). XRCC1 keeps DNA from getting stranded. Mutat Res, 459, 1-18.
18. Wang Y, Spitz MR, Zhu Y, et al (2003). From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst), 2, 901-8.
19. Wu K, Su D, Lin K, et al (2011). XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Asian Pac J Cancer Prev, 12, 2237-43.
20. Yang JL, Han YN, Zheng SG (2004). Influence of human XRCC1-399 single nucleotide polymorphism on primary hepatocytic carcinoma. Zhong Liu, 24, 322-4 (article in Chinese).
21. Yu HP, Zhang XY, Wang XL, et al (2004). DNA repair gene XRCC1 polymorphisms,smoking, and esophageal cancer risk. Cancer Detect Prev, 28, 194-9.
22. Yu MW, Yang SY, Pan IJ, et al (2003). Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst, 95, 1485-8.
23. Zintzaras E, Loannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol, 28, 123-37.